drugset

drugset / Trial / NCT07201064

A Study of SZ1003 Injection in Patients With Advanced Hepatocellular Carcinoma

NCT07201064 ↗

Phase 0 Not yet recruiting 12 enrolled Guangdong ProCapZoom Biosciences Co., Ltd.

NaSingle-groupOpen-labelTreatment

Summary

This study is a "3+3" dose-escalation, open-label, multiple-dose clinical trial.

Timeline

Start: 2025-09-25
Primary completion: 2027-03-30
Completion: 2027-09-30

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	SZ1003	Unknown	—	—

Indications